High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma | Zendy

Zhiying Xu | Zendy; Yidong Liu | Zendy; Yuanfeng Yang | Zendy; Jieti Wang | Zendy; Guodong Zhang | Zendy; Zheng Liu | Zendy; Hangcheng Fu | Zendy; Zewei Wang | Zendy; Haiou Liu | Zendy; Jiejie Xu | Zendy

Open Access

High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma

Author(s) -

Zhiying Xu,

Yidong Liu,

Yuanfeng Yang,

Jieti Wang,

Guodong Zhang,

Zheng Liu,

Hangcheng Fu,

Zewei Wang,

Haiou Liu,

Jiejie Xu

Publication year - 2016

Publication title -

oncotarget

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.373

H-Index - 127

ISSN - 1949-2553

DOI - 10.18632/oncotarget.13692

Subject(s) - clear cell renal cell carcinoma , medicine , renal cell carcinoma , oncology , nomogram , clear cell carcinoma , carcinoma , gynecology

Mucin13 (MUC13) is a transmembrane glycoprotein that is aberrantly expressed in ovarian and gastro-intestinal tumors, but its role in renal cell carcinoma remains elusive. The purpose of this study is to evaluate the prognostic value of MUC13 expression in patients with non-metastatic clear cell renal cell carcinoma (ccRCC) after surgical resection.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research